In addition to improved symptoms, a delayed-release/extended-release methylphenidate was linked with improvements in early morning and late afternoon/evening functional impairment experienced by children with ADHD.
Higher rates of hopelessness, loneliness, anhedonia, social anxiety, and younger age were highly correlated with suicidal ideation in patients with major depressive disorder, based on a review of qualitative data.
Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.
Blood pressure should be assessed before treatment with esketamine nasal spray in patients with treatment-resistant depression.
